Home > Insider Trading > Filing (0001209191-21-058527)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1490829	James Jones	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-01	42	$2.88	16,338	No	4	P	Direct
Common Stock	Acquisiton	2021-09-02	42	$2.88	16,380	No	4	P	Direct
Common Stock	Acquisiton	2021-09-03	42	$2.85	16,422	No	4	P	Direct
Common Stock	Acquisiton	2021-09-07	42	$2.79	16,464	No	4	P	Direct
Common Stock	Acquisiton	2021-09-08	42	$2.89	16,506	No	4	P	Direct
Common Stock	Acquisiton	2021-09-09	42	$2.77	16,548	No	4	P	Direct
Common Stock	Acquisiton	2021-09-10	42	$2.78	16,590	No	4	P	Direct
Common Stock	Acquisiton	2021-09-13	42	$2.96	16,632	No	4	P	Direct
Common Stock	Acquisiton	2021-09-14	42	$3.02	16,674	No	4	P	Direct
Common Stock	Acquisiton	2021-09-15	42	$2.86	16,716	No	4	P	Direct
Common Stock	Acquisiton	2021-09-16	42	$2.91	16,758	No	4	P	Direct
Common Stock	Acquisiton	2021-09-17	42	$2.85	16,800	No	4	P	Direct
Common Stock	Acquisiton	2021-09-20	42	$2.82	16,842	No	4	P	Direct
Common Stock	Acquisiton	2021-09-21	42	$2.81	16,884	No	4	P	Direct
Common Stock	Acquisiton	2021-09-22	42	$2.76	16,926	No	4	P	Direct
Common Stock	Acquisiton	2021-09-23	42	$2.75	16,968	No	4	P	Direct
Common Stock	Acquisiton	2021-09-24	42	$2.74	17,010	No	4	P	Direct
Common Stock	Acquisiton	2021-09-27	42	$2.79	17,052	No	4	P	Direct
Common Stock	Acquisiton	2021-09-28	42	$2.76	17,094	No	4	P	Direct
Common Stock	Acquisiton	2021-09-29	42	$2.82	17,136	No	4	P	Direct
Common Stock	Acquisiton	2021-09-30	42	$2.72	17,178	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.